[Federal Register Volume 66, Number 103 (Tuesday, May 29, 2001)]
[Notices]
[Page 29152]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-13378]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Science Advisory Board to the National Center for Toxicological
Research; Notice of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). At least one
portion of the meeting will be closed to the public.
Name of Committee: Science Advisory Board to the National Center
for Toxicological Research (NCTR).
General Function of the Committee: The board advises the Director,
NCTR, in establishing, implementing, and evaluating the research
programs that assist the Commissioner of Food and Drugs (the
Commissioner) in fulfilling regulatory responsibilities. The board
provides an extra-agency review in ensuring that the research programs
at NCTR are scientifically sound and pertinent.
Date and Time: The meeting will be held on June 11, 2001, 1 p.m. to
5:30 p.m., and June 12, 2001, 8:30 a.m. to 1 p.m.
Location: NCTR, Bldg. #12, Conference Center, Jefferson, AR.
Contact: Leonard M. Schechtman, NCTR (HFT-10), Food and Drug
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-6696,
or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-
0572 in the Washington, DC area), code 12559. Please call the
Information Line for up-to-date information on this meeting.
Agenda: The board will be presented with progress reports on the
implementation of recommendations made by the board at its last meeting
on NCTR's research programs in endocrine disrupter knowledge base and
microbiology. The NCTR director will provide a center update and a
discussion of future research directions. A proposal will be made to
the board that it consider establishing a subcommittee on scientific
opportunities to improve regulatory science through collaboration with
external stakeholders. A report will be provided to the board on the
activities of an existing subcommittee with a similar focus (Advisory
Committee for Pharmaceutical Science, Nonclinical Studies Subcommittee)
NCTR division directors will discuss the accomplishments and future
directions for their divisions.
Procedure: On June 11, 2001, from 1 p.m. to 5:30 p.m., and June 12,
2001, from 8:30 a.m. to 12 noon, the meeting is open to the public.
Interested persons may present data, information, or views, orally or
in writing, on issues pending before the committee. Written submissions
may be made to the contact person by May 18, 2001. Oral presentations
from the public will be scheduled between approximately 11 a.m. and 12
noon on June 12, 2001. Time allotted for each presentation may be
limited. Those desiring to make formal oral presentations should notify
the contact person before May 18, 2001, and submit a brief statement of
the general nature of the evidence or arguments they wish to present,
the names and addresses of proposed participants, and an indication of
the approximate time requested to make their presentation.
Closed Committee Deliberations: On June 12, 2001, from 12 noon to 1
p.m., the meeting will be closed to permit discussion where disclosure
would constitute a clearly unwarranted invasion of personal privacy (5
U.S.C. 552b(c)(6)). This portion of the meeting will be closed to
permit discussion of information concerning individuals associated with
the research programs at NCTR.
The Commissioner approves the scheduling of meetings at locations
outside the Washington, DC area on the basis of the criteria of 21 CFR
14.22 of FDA's regulations relating to public advisory committees.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: May 22, 2001.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 01-13378 Filed 5-25-01; 8:45 am]
BILLING CODE 4160-01-S